Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2018-09-21

New medicine for the prevention of migraine

View source ↗

Summary

The EMA announces a new medicine for the prevention of migraine, representing a new option for preventive treatment pending regulatory approval in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications